Answers are grounded in this paper and cite their sources.
The number of deaths from cryptococcal meningitis is around 180,000 per year. The disease is the second leading cause of mortality among individuals with AIDS. Antifungal treatment is costly and associated with adverse effects and resistance, evidencing the urgency of development of both therapeutic and prophylactic tools. Here we demonstrate the key roles of polysaccharide- and glycolipid-containing structures in a vaccination model to prevent cryptococcosis.
No takes yet. Share an insight, caveat, or question.
Colombo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: